Background: Meningiomas are common central nervous system neoplasms, accounts for 30% of all primary intracranial neoplasms; the occurrence of meningiomas with cystic lesions is an exceptionally rare. Lymphoplasmacyte-rich meningioma (LPRM) is a rare pathological entity belong to the World Health Organization Grade I meningiomas. LPRM is characterized by abundant lymphoplasmacytic infiltrates which over-shadow the underlying meningothelial component. Case Description: A 42-year-old male was admitted to our hospital with a chronic headache for about 3 weeks prior to admission. His symptoms worsen, and subsequently, he experienced left extremities weakness about 1 week before admission. His brain magnetic resonance imaging revealed an irregular and heterogeneously enhancing solid lesion with intratumoral cystic changes at the temporal lobe. A gross total resection was performed; pathological examination revealed a cystic LPRM. Conclusion: This rare variant of meningioma is a benign tumor entity featured with massive inflammatory cell infiltration and often less proportion of meningothelial elements. Surgical resection remains the treatment of choice. This is the first report regarding cystic LPRM from Indonesia; we also summarized relevant literature upto-date, May 2020, reported LPRM cases.

ABSTRAKLimfoma komposit merupakan penyakit yang jarang terjadi. Limfoma komposit merupakan dua atau lebih tipe limfoma berbeda yang terjadi pada satu lokasi anatomi, baik secara bersamaan maupun sekuensial. Proses diagnostik limfoma komposit memiliki tantangan tersendiri dan sampai saat ini belum ada panduan khusus mengenai tata laksana limfoma komposit. Tulisan ini melaporkan sebuah kasus, pasien wanita 36 tahun dengan limfoma komposit yang terdiri dari limfoma Hodgkin dan limfoma non-Hodgkin yang terjadi sekuensial. ABSTRACTComposite lymphoma (CL) is a rare disease. Composite lymphoma is two or more different type of lymphoma that sequentially or simultaneously occur in one anatomical site. Making a diagnosis of CL is a challenge and there is still no guidelines about the treatment. This case report is about a 36 y.o female with CL, sequentially consisted of Hodgkin and non-Hodgkin lymphoma.